Iatrogenic Cushing Syndrome Secondary to Ritonavir-Epidural Triamcinolone Interaction: An Illustrative Case and Review
Open Access
- 7 May 2014
- journal article
- review article
- Published by Hindawi Limited in Interdisciplinary Perspectives on Infectious Diseases
- Vol. 2014, 1-7
- https://doi.org/10.1155/2014/849432
Abstract
HIV positive patients on ritonavir-containing antiretroviral therapy (ART) can develop iatrogenic Cushing syndrome (IACS) and adrenal insufficiency as a result of drug-drug interactions with inhaled or intranasal glucocorticoid therapy. Reports related to epidural triamcinolone injections are relatively uncommon but increasingly reported. We describe a 48-year-old woman with immunologically and virologically well-controlled HIV on ritonavir-based ART, who developed headache, dizziness, and candida and herpes simplex virus (HSV) ulcerative esophagitis 7 days after receiving an epidural triamcinolone injection for cervical radicular pain. Iatrogenic Cushing syndrome and relative adrenal insufficiency were suspected and proven. The patients ART was changed to a non-HIV protease inhibitor- (PI-) containing program, her symptoms improved, and she did not require hydrocortisone replacement. In this paper, we review the literature on IACS and relative secondary adrenal insufficiency from epidural triamcinolone injections in HIV patients on ritonavir-containing ART regimens. A high index of clinical suspicion is needed for diagnosis. Prevention of drug-drug interactions by taking a thorough medication history for patients on ritonavir-containing ART regimens before prescribing any form of corticosteroid is crucial and effective and sustained interdisciplinary communication in the care of such patients.Keywords
This publication has 19 references indexed in Scilit:
- Triamcinolone and ritonavir leading to drug-induced Cushing syndrome and adrenal suppression: description of a new case and review of the literatureInfection, 2013
- Iatrogenic hypercortisolism complicating triamcinolone acetonide injections in patients with HIV on ritonavir-boosted protease inhibitors.2012
- Injecting epidural and intra-articular triamcinolone in HIV-positive patients on ritonavir: beware of iatrogenic Cushing’s syndromeSkeletal Radiology, 2012
- Ritonavir and Epidural Triamcinolone as a Cause of Iatrogenic Cushing’s SyndromeThe American Journal of the Medical Sciences, 2012
- Iatrogenic Cushing syndrome after a single intramuscular corticosteroid injection and concomitant protease inhibitor therapyJournal of the American Academy of Dermatology, 2011
- Adrenal suppression due to an interaction between ritonavir and injected triamcinolone: a case reportAIDS Research and Therapy, 2009
- Iatrogenic Cushing Syndrome after Epidural Triamcinolone Injections in an HIV Type 1–Infected Patient Receiving Therapy with Ritonavir‐LopinavirClinical Infectious Diseases, 2008
- Proposal for a New Tool to Evaluate Drug Interaction CasesAnnals of Pharmacotherapy, 2007
- Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administrationCancer Cell, 1986
- Rapid adrenocorticotropic hormone test in practice. Retrospective reviewAmerican Journal Of Medicine, 1985